MicroRNA-124 mediates the cholinergic anti-inflammatory action through inhibiting the production of pro-inflammatory cytokines

Cell Research

Volumn 23, Issue 11, 2013, Pages 1270-1283

  Sun, Yang ^a   Li, Qi ^a   Gui, Huan ^a   Xu, Dong Ping ^a   Yang, Yi Li ^b   Su, Ding Feng ^a   Liu, Xia ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

7nAChR; cholinergic anti inflammatory action; macrophages; microRNA 124; septic shock; STAT3; TACE

Indexed keywords

MUS;

ADAM PROTEIN; BUNGAROTOXIN RECEPTOR; CYTOKINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MICRORNA; MIRN124 MICRORNA, HUMAN; MIRN124 MICRORNA, MOUSE; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED; CHOLINERGIC NERVE CELL; GENETIC TRANSCRIPTION; GENETICS; HEK293 CELL LINE; HUMAN; MACROPHAGE; METABOLISM; MOUSE; PATHOLOGY; SECRETION (PROCESS); SEPSIS;

ADAM PROTEINS; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; CELLS, CULTURED; CHOLINERGIC NEURONS; CYTOKINES; HEK293 CELLS; HUMANS; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICRORNAS; SEPSIS; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887240627     PISSN: 10010602     EISSN: 17487838     Source Type: Journal    
DOI: 10.1038/cr.2013.116     Document Type: Article

References (51)

1. Medzhitov R. Origin and physiological roles of infammation. Nature 2008; 454:428-435.
2. Nathan C. Points of control in inflammation. Nature 2002; 420:846-852. (Pubitemid 36019637)
3. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol 2002; 20:125-163. (Pubitemid 34295785)
4. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic infammatory response to endo-toxin. Nature 2000; 405:458-462. (Pubitemid 30367422)
5. Ulloa L. The vagus nerve and the nicotinic anti-infammatory pathway. Nat Rev Drug Discov 2005; 4:673-684. (Pubitemid 41149761)
6. Rosas-Ballina M, Olofsson PS, Ochani M, et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 2011; 334:98-101.
7. Pena G, Cai B, Ramos L, Vida G, Deitch EA, Ulloa L. Cholin-ergic regulatory lymphocytes re-establish neuromodulation of innate immune responses in sepsis. J Immunol 2011; 187:718-725.
8. Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10:1216-1221. (Pubitemid 39540438)
9. Marrero MB, Bencherif M, Lippiello PM, Lucas R. Application of alpha7 nicotinic acetylcholine receptor agonists in infam-matory diseases: an overview. Pharm Res 2011; 28:413-416.
10. Zhao M, He X, Bi XY, Yu XJ, Gil Wier W, Zang WJ. Vagal stimulation triggers peripheral vascular protection through the cholinergic anti-infammatory pathway in a rat model of myocardial ischemia/reperfusion. Basic Res Cardiol 2013; 108:345.
11. Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: The non-neuronal cholinergic system in humans. Br J Pharmacol 2008; 154:1558-1571.
12. Khiroug L, Giniatullin R, Klein RC, Fayuk D, Yakel JL. Functional mapping and Ca2+ regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons. J Neurosci 2003; 23:9024-9031. (Pubitemid 37243803)
13. Bitner RS, Bunnelle WH, Anderson DJ, et al. Broad-spectrum effcacy across cognitive domains by alpha7 nicotinic acetyl-choline receptor agonism correlates with activation of ERK/2 and CREB phosphorylation pathways. J Neurosci 2007; 27:10578-10587. (Pubitemid 47502013)
14. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421:384-388. (Pubitemid 36157937)
15. Huang Y, Shen XJ, Zou Q, Wang SP, Tang SM, Zhang GZ. Biological functions of microRNAs: a review. J Physiol Biochem 2011; 67:129-139.
16. Karginov F V, Conaco C, Xuan Z, et al. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci USA 2007; 104:19291-19296.
17. O'Connell RM, Rao DS, Baltimore D. MicroRNA regulation of infammatory responses. Annu Rev Immunol 2012; 30:295-312.
18. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. Modulation of microRNA processing by p53. Nature 2009; 460:529-533.
19. Waldburger JM, Boyle DL, Pavlov VA, Tracey KJ, Firestein GS. Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum 2008; 58:3439-3449.
20. Ponomarev ED, Veremeyko T, Barteneva N, Krichevsky AM, Weiner HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU.1 pathway. Nat Med 2011; 17:64-70.
21. Tsitsiou E, Lindsay MA. MicroRNAs and the immune response. Curr Opin Pharmacol. 2009; 9:514-520.
22. Tili E, Michaille JJ, Cimino A, et al. Modulation of mir-155 and mir-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007; 179:5082-5089.
23. Quinn SR, O'Neill LA. A trio of microRNAs that control Tolllike receptor signalling. Int Immunol 2011; 23:421-425.
24. Huston JM, Ochani M, Rosas-Ballina M, et al. Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006; 203:1623-1628.
25. Rosas-Ballina M, Ochani M, Parrish WR, et al. Splenic nerve is required for cholinergic antiinflammatory pathway control of TNF in endotoxemia. Proc Natl Acad Sci USA 2008; 105:11008-11013.
26. Moss ML, Jin SL, Milla ME, et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 1997; 385:733-736. (Pubitemid 27098095)
27. Smookler DS, Mohammed FF, Kassiri Z, Duncan GS, Mak TW, Khokha R. Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic infammation. J Immunol 2006; 176:721-725. (Pubitemid 43099666)
28. Horiuchi K, Kimura T, Miyamoto T, et al. Cutting edge: TNF-alpha-converting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J Immunol 2007; 179:2686-2689.
29. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348:138-150. (Pubitemid 36056721)
30. Feldmann M. Development of anti-TNF therapy for rheumatoid arthritis. Nat Rev Immunol 2002; 2:364-371. (Pubitemid 37328759)
31. Van Assche G, Rutgeerts P. Anti-TNF agents in crohn's disease. Expert Opin Investig Drugs 2000; 9:103-111. (Pubitemid 30011552)
32. Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol 2010; 10:89-102.
33. Fry DE. Sepsis, systemic infammatory response, and multiple organ dysfunction: the mystery continues. Am Surg 2012; 78:1-8.
34. Andersson U, Tracey KJ. Refex principles of immunological homeostasis. Annu Rev Immunol 2012; 30:313-335.
35. Lakhan SE, Kirchgessner A. Anti-inflammatory effects of nicotine in obesity and ulcerative colitis. J Transl Med 2011; 9:129.
36. Lindenblatt C, Schulze-Osthoff K, Totzke G. Iκbζ expression is regulated by miR-124a. Cell Cycle 2009; 8:2019-2023.
37. Yamamoto M, Yamazaki S, Uematsu S, et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 2004; 430:218-222. (Pubitemid 38902431)
38. Li Q, Zhou XD, Kolosov VP, Perelman JM. Nicotine reduces TNF-α expression through a α7 nAChR/MyD88/NF-κb pathway in HBE16 airway epithelial cells. Cell Physiol Biochem 2011; 27:605-612.
39. Park SY, Baik YH, Cho JH, Kim S, Lee KS, Han JS. Inhibition of lipopolysaccharide-induced nitric oxide synthesis by nicotine through S6K1-p42/44 MAPK pathway and STAT3 (Ser 727) phosphorylation in Raw 264.7 cells. Cytokine 2008; 44:126-134.
40. Chatterjee PK, Al-Abed Y, Sherry B, Metz CN. Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endotheli-al cell activation. Am J Physiol Cell Physiol 2009; 297:C1294-C1306.
41. de Jonge WJ, van der Zanden EP, The FO, et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 2005; 6:844-851. (Pubitemid 43090471)
42. Pena G, Cai B, Liu J, et al. Unphosphorylated STAT3 modulates α7 nicotinic receptor signaling and cytokine production in sepsis. Eur J Immunol 2010; 40:2580-2589.
43. Samavati L, Rastogi R, Du W, Huttemann M, Fite A, Franchi L. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysac-charide and live bacteria. Mol Immunol 2009; 46:1867-1877.
44. Lee C, Lim HK, Sakong J, Lee YS, Kim JR, Baek SH. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production. Mol Pharmacol 2006; 69:1041-1047. (Pubitemid 43363880)
45. Yu Z, Zhang W, Kone BC. Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem J 2002; 367:97-105. (Pubitemid 35176895)
46. Lee H, Herrmann A, Deng JH, et al. Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors. Cancer Cell 2009; 15:283-293.
47. Huang WL, Yeh HH, Lin CC, et al. Signal transducer and activator of transcription 3 activation up-regulates interleukin-6 autocrine production: a biochemical and genetic study of established cancer cell lines and clinical isolated human cancer cells. Mol Cancer 2010; 9:309.
48. Cai B, Li J, Wang J, et al. microRNA-124 regulates cardiomyo-cyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling. Stem Cells 2012; 30:1746-1755.
49. Hatziapostolou M, Polytarchou C, Aggelidou E, et al. An HNF4α-miRNA infammatory feedback circuit regulates hepa-tocellular oncogenesis. Cell 2011; 147:1233-1247.
50. Hou J, Wang P, Lin L, et al. MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009; 183:2150-2158.
51. Wang C, Chen T, Zhang J, et al. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type 1 interferon. Nat Immunol 2009; 10:744-752.